News
In clinical trials, Blujepa showed efficacy similar or superior to a leading existing UTI ... have a new medication option now that the U.S. Food and Drug Administration (FDA) has approved the ...
March 26, 2025 — The FDA has approved a new medication to treat uncomplicated ... About half of all women get a UTI at least once in their lifetime, and 30% may face recurring infections.
The Food and Drug Administration (FDA) has approved a new drug for treating urinary ... adults and pediatric patients 12 and older. A UTI is considered uncomplicated if it occurs in a female ...
Blujepa is approved to treat females 12 and older with uncomplicated urinary tract infections, or UTIs. About half of all women will experience a UTI at some point in their lives, and about 30% ...
Blujepa is approved to treat females 12 and older with uncomplicated urinary tract infections, or UTIs. About half of all women will experience a UTI at some point in their lives, and about 30% ...
A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving ... Meanwhile, the FDA also approved Genetech's TNKase to treat adults who suffer acute ischemic ...
The Food and Drug Administration (FDA) has approved a new drug ... and half of all women experience a UTI in their lifetime, with some 30% of women suffering from recurrent episodes.
Read on to learn how to prevent a UTI, including common causes, advice for specific situations, and OBGYN-approved tips to ... or when starting a new medication. "Another thing that can increase ...
In clinical trials, Blujepa showed efficacy similar or superior to a leading existing UTI ... have a new medication option now that the U.S. Food and Drug Administration (FDA) has approved the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results